Mon, July 18, 2022
Sat, July 16, 2022
Fri, July 15, 2022
Thu, July 14, 2022

Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $293 on, Jul 15th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-293-on-jul-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $300 to $293 on, Jul 15th, 2022.

Matthew has made no other calls on BGNE in the last 4 months.



There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $177 on, Thursday, March 17th, 2022